Literature DB >> 33946622

Resistivity Technique for the Evaluation of the Integrity of Buccal and Esophageal Epithelium Mucosa for In Vitro Permeation Studies: Swine Buccal and Esophageal Mucosa Barrier Models.

Jaiza Samara Macena de Araújo1, Maria Cristina Volpato1, Bruno Vilela Muniz1, Gabriela Gama Augusto Xavier1, Claudia Cristina Maia Martinelli1, Renata Fonseca Vianna Lopez2, Francisco Carlos Groppo1, Michelle Franz-Montan1.   

Abstract

Permeation assays are important for the development of topical formulations applied on buccal mucosa. Swine buccal and esophageal epithelia are usually used as barriers for these assays, while frozen epithelia have been used to optimize the experimental setup. However, there is no consensus on these methods. In transdermal studies, barrier integrity has been evaluated by measuring electrical resistance (ER) across the skin, which has been demonstrated to be a simple, fast, safe, and cost-effective method. Therefore, the aims here were to investigate whether ER might also be an effective method to evaluate buccal and esophageal epithelium mucosa integrity for in vitro permeation studies, and to establish a cut-off ER value for each epithelium mucosa model. We further investigated whether buccal epithelium could be substituted by esophageal epithelium in transbuccal permeation studies, and whether their permeability and integrity were affected by freezing at -20 °C for 3 weeks. Fresh and frozen swine buccal and esophageal epithelia were mounted in Franz diffusion cells and were then submitted to ER measurement. Permeation assays were performed using lidocaine hydrochloride as a hydrophilic drug model. ER was shown to be a reliable method for evaluating esophageal and buccal epithelia. The esophageal epithelium presented higher permeability compared to the buccal epithelium. For both epithelia, freezing and storage led to decreased electrical resistivity and increased permeability. We conclude that ER may be safely used to confirm tissue integrity when it is equal to or above 3 kΩ for fresh esophageal mucosa, but not for buccal epithelium mucosa. However, the use of esophageal epithelium in in vitro transmucosal studies could overestimate the absorption of hydrophilic drugs. In addition, fresh samples are recommended for these experiments, especially when hydrophilic drugs are involved.

Entities:  

Keywords:  buccal epithelium; esophageal epithelium; in vitro models; membrane resistivity; mucosal drug delivery; transbuccal drug delivery

Year:  2021        PMID: 33946622     DOI: 10.3390/pharmaceutics13050643

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  41 in total

1.  Passive and iontophoretic transport through the skin polar pathway.

Authors:  S K Li; K D Peck
Journal:  Skin Pharmacol Physiol       Date:  2013-07-29       Impact factor: 3.479

2.  DC electrical properties of frozen, excised human skin.

Authors:  G B Kasting; L A Bowman
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

3.  Striving Towards the Perfect In Vitro Oral Drug Absorption Model.

Authors:  John P Gleeson; Fiona McCartney
Journal:  Trends Pharmacol Sci       Date:  2019-08-16       Impact factor: 14.819

Review 4.  Novel strategies for the buccal delivery of macromolecules.

Authors:  Javier O Morales; Jason T McConville
Journal:  Drug Dev Ind Pharm       Date:  2014-03-10       Impact factor: 3.225

5.  Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models.

Authors:  Fabíola Silva Garcia Praça; Wanessa Silva Garcia Medina; Josimar O Eloy; Raquel Petrilli; Patrícia Mazureki Campos; Andreia Ascenso; Maria Vitória L B Bentley
Journal:  Eur J Pharm Sci       Date:  2017-09-23       Impact factor: 4.384

6.  Evaluation of different pig oral mucosa sites as permeability barrier models for drug permeation studies.

Authors:  Michelle Franz-Montan; Luciano Serpe; Claudia Cristina Maia Martinelli; Camila Batista da Silva; Cleiton Pita Dos Santos; Pedro Duarte Novaes; Maria Cristina Volpato; Eneida de Paula; Renata Fonseca Vianna Lopez; Francisco Carlos Groppo
Journal:  Eur J Pharm Sci       Date:  2015-10-03       Impact factor: 4.384

7.  Guidance on dermal absorption.

Authors:  Harrie Buist; Peter Craig; Ian Dewhurst; Susanne Hougaard Bennekou; Carsten Kneuer; Kyriaki Machera; Christina Pieper; Daniele Court Marques; Gilles Guillot; Federica Ruffo; Arianna Chiusolo
Journal:  EFSA J       Date:  2017-06-30

8.  Development, validation and standardization of oromucosal ex-vivo permeation studies for implementation in quality-controlled environments.

Authors:  Haidara Majid; Anke Bartel; Bjoern B Burckhardt
Journal:  J Pharm Biomed Anal       Date:  2020-11-20       Impact factor: 3.935

9.  Effect of Temperature on the Structure, Electrical Resistivity, and Charge Capacitance of Supported Lipid Bilayers.

Authors:  Shiju Abraham; Tabea Heckenthaler; Yakov Morgenstern; Yair Kaufman
Journal:  Langmuir       Date:  2019-06-20       Impact factor: 3.882

10.  The oral mucosal surface and blood vessels.

Authors:  Ella A Naumova; Tobias Dierkes; Jürgen Sprang; Wolfgang H Arnold
Journal:  Head Face Med       Date:  2013-03-12       Impact factor: 2.151

View more
  3 in total

1.  A method for evaluating drug penetration and absorption through isolated buccal mucosa with highly accuracy and reproducibility.

Authors:  Shuangqing Wang; Lei Liu; Saige Meng; Yuling Wang; Daofeng Liu; Zhonggao Gao; Along Zuo; Jianpeng Guo
Journal:  Drug Deliv Transl Res       Date:  2022-03-29       Impact factor: 5.671

2.  Polymeric Micelles Enhance Mucosal Contact Time and Deposition of Fluocinolone Acetonide.

Authors:  Sucharat Limsitthichaikoon; Siriwat Soontaranon; Nuntachai Hanpramukkun; Kanjana Thumanu; Aroonsri Priprem
Journal:  Polymers (Basel)       Date:  2022-05-31       Impact factor: 4.967

3.  In Vitro Skin Delivery of Griseofulvin by Layer-by-Layer Nanocoated Emulsions Stabilized by Whey Protein and Polysaccharides.

Authors:  Daniel P Otto; Anja Otto; Melgardt M de Villiers
Journal:  Pharmaceutics       Date:  2022-03-02       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.